The third edition of Hypertension: A Companion to Braunwald's Heart Disease, by Drs. George L. Bakris and Matthew Sorrentino, focuses on every aspect of managing and treating patients who suffer from hypertensive disorders. Designed for cardiologists, endocrinologists and nephrologists alike, this expansive, in-depth review boasts expert guidance from contributors worldwide, keeping you abreast of the latest developments from basic science to clinical trials and guidelines. Hypertension also includes an Expert Consult eBook updated with late-breaking clinical trials, reviews of important new articles, and the latest guidance on clinical practice, all selected and masterfully edited by Dr. Eugene Braunwald.
New to this edition
Covers new developments in epidemiology, pathophysiology, immunology, clinical findings, laboratory testing, invasive and non-invasive testing, risk stratification, clinical decision-making, prognosis, and management.
Includes chapters on hot topics such as hypertension as an immune disease; sleep disorders including sleep apnea, a major cause of hypertension; a novel chapter on environmental pollution and its contribution to endothelial dysfunction, and more!
Equips you with the most recent guidelines from the major societies.
Updates sourced from the main Braunwald's Heart Disease text.
Highlights new combination drug therapies and the management of chronic complications of hypertension.
Table of Contents:
SECTION I: EPIDEMIOLOGY
1. General Population and Global Cardiovascular Risk Prediction
2. Hypertension in Latin/Hispanic Population
3. Hypertension in East Asians and Native Hawaiians
4. Hypertension in South Asians
SECTION II: PATHOPHYSIOLOGY
5. Pathogenesis of Hypertension
6. Genetics of Hypertension
7. Inflammation and Immunity in Hypertension
SECTION III: DIAGNOSIS AND EVALUATION
8. The Environment and High Blood Pressure
9. Office Blood Pressure Measurement
10. Home Monitoring of Blood Pressure
11. Ambulatory Blood Pressure Monitoring in Clinical Hypertension Management
12. White Coat and Masked Hypertension
13. Renovascular Hypertension and Ischemic Nephropathy
14. Secondary Hypertension: Primary Hyperaldosteronism and Mineralocorticoid Excess States
15. Secondary Hypertension: Pheochromocytoma and Paraganglioma
16. Secondary Hypertension: Sleep Disturbances including Sleep Apnea
17. Hypertension in Children: Diagnosis and Treatment
SECTION IV: RISK STRATIFICATION
18. Natural History of Untreated Hypertension
19. Isolated Systolic Hypertension
20. Assessment of Target Organ Damage
SECTION V: ANTIHYPERTENSIVE THERAPY
21. Diet and Blood Pressure
22. Diuretics in Hypertension
23. Alpha Blockers and Hypertension
24. Renin Angiotensin Aldosterone System Blockers
25. Calcium Channel Blockers
26. Central Sympathetic Agents and Direct Vasodilators
27. Use of Combination Therapies
28. Devices Therapies
29. Alternative Approaches for Lowering Blood Pressure
SECTION VI: HYPERTENSION MANAGEMENT
30. Approach to Difficult to Manage Primary Hypertension
31. Hypertension in Ischemic Heart Disease
32. Heart Failure
33. Hypertension and Chronic Kidney Disease
34. Transplant Hypertension
35. Obesity
36. Cerebrovascular Disease
37. Diabetes Mellitus
38. Dyslipidemia
SECTION VII: SPECIAL POPULATIONS AND SPECIAL SITUATIONS
39. Hypertension in Pregnancy
40. Hypertension in Older People
41. Hypertension in African Americans
42. Baroreceptor Dysfunction/Orthostatic Hypotension
43. Resistant Hypertension
44. Hypertension and the Perioperative Period
45. Aorta and Peripheral Arterial Disease in Hypertension
46. Hypertensive Emergencies and Urgencies
SECTION VIII: OUTCOME TRIALS
47. Meta-Analyses of Blood Pressure Lowering Trials and the Blood Pressure Lowering Treatment Trialists’ Collaboration
SECTION IX: HYPERTENSION TREATMENT IN THE FUTURE
48. Team-Based Care for Hypertension Management
49. Understanding and Improving Medication Adherence
SECTION X: GUIDELINES
50. Updated AHA/ACC; ESH/ISH
51. Putting All Guidelines into Perspective
